Palantir Stock Spikes on U.S. Army TITAN Contract Hosted by Laycee KluinMarch 6, 2024 ShareLink copied to clipboard. Play video for Palantir Stock Spikes on U.S. Army TITAN ContractDetailsGuestsThe share price of Palantir Technologies Inc. NYSE: PLTR was sharply higher in pre-market trading on March 6, 2024. The company announced it has been awarded a two-year $178 million contract from the U.S. Army for its Tactical Intelligence Targeting Access Node (TITAN) program. These are mobile ground stations that are powered by artificial intelligence (AI) and machine learning (ML) technology. The TITAN system's mission is to provide real-time actionable intelligence using AI and ML modeling that can be implemented at the tactical edge. Palantir's AIP platform will provide a best-in-class solution that will lay the foundation for a scalable, adaptable solution designed for a rapidly evolving threat environment. Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E Ratio Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored7 Alcohol Stocks Primed to Pour ProfitsIn 2020 and 2021, alcohol stocks were among the best-performing consumer staples stocks. But it's been a diffe...MarketBeatThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored7 Stocks to Buy as the Travel Bubble Shows No Signs of BurstingIn 2020, travel stocks were in bad shape. Many hotels and airlines faced short-term revenue declines of up to ...MarketBeatThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersWhy Wells Fargo Is Buying $40 Billion of Its Own StockMay 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockThis next market event could mean total financial ruin for someFrom Weiss Ratings(Ad)View This next market event could mean total financial ruin for someRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMay 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring Expectations3 Mid-Cap Medical Stocks Outperforming the MarketMay 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the Market5 Stocks That Crushed Earnings and Guidance ForecastsMay 8, 2025View 5 Stocks That Crushed Earnings and Guidance ForecastsURGENT: This Altcoin Opportunity Won’t Wait – Act NowFrom Crypto Swap Profits(Ad)View URGENT: This Altcoin Opportunity Won’t Wait – Act Now Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinMarch 6, 2024 ShareLink copied to clipboard. Play video for Palantir Stock Spikes on U.S. Army TITAN ContractDetailsGuestsThe share price of Palantir Technologies Inc. NYSE: PLTR was sharply higher in pre-market trading on March 6, 2024. The company announced it has been awarded a two-year $178 million contract from the U.S. Army for its Tactical Intelligence Targeting Access Node (TITAN) program. These are mobile ground stations that are powered by artificial intelligence (AI) and machine learning (ML) technology. The TITAN system's mission is to provide real-time actionable intelligence using AI and ML modeling that can be implemented at the tactical edge. Palantir's AIP platform will provide a best-in-class solution that will lay the foundation for a scalable, adaptable solution designed for a rapidly evolving threat environment. Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E Ratio Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored7 Alcohol Stocks Primed to Pour ProfitsIn 2020 and 2021, alcohol stocks were among the best-performing consumer staples stocks. But it's been a diffe...MarketBeatThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored7 Stocks to Buy as the Travel Bubble Shows No Signs of BurstingIn 2020, travel stocks were in bad shape. Many hotels and airlines faced short-term revenue declines of up to ...MarketBeatThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeat
